Recently Opened Study: Triple Negative Breast Cancer Program

The Weill Cornell Breast Center recently opened a new triple negative breast cancer program. The study is for women diagnosed with triple negative breast cancer. There is an urgent need to develop new, targeted treatments for triple negative breast cancer. Through our Program, we plan to integrate research, treatment and education to accelerate and identify new targets and strategies to treat and cure triple negative breast cancer.

For more information about the study, please call Margie for a consult appointment with Dr. Vahdat at (212)-821-0644 and contact Naomi for more information at (212)-821-0984 or naw2007@med.cornell.edu.

“From a patient perspective this study requires very little of participants.  I think that for post-treatment women like me the opportunity to participate so easily in cutting edge research at a world-class institution like WCMC is a great way to ‘pay it forward’ in appreciation to all those women whose participation in past clinical trials directly benefited us in terms of improvements in how breast cancer is treated. This is an exceedingly rare opportunity!”

– Triple Negative Breast Cancer Program participant

MasterCard Gives Grant to Weill Cornell for Women’s Cancer Research

MasterCard has announced a $500,000 grant to Weill Cornell Medical College to support women’s cancer research.

The grant will be used to to start or continue scientific investigations in developing breakthrough therapies in a variety of women’s cancers including breast, ovarian, and uterine cancer.

Click here to read the press release.

Dr. Vahdat Presents Metastatic Breast Cancer Research Update Webinar

Dr. Vahdat

Dr. Vahdat

Dr. Linda Vahdat, director of the Weill Cornell Breast Center Research Program and Chief of the Solid Tumor Service at Weill Cornell, will be presenting a metastatic breast cancer research update for Living Beyond Breast Cancer’s free webinar on
Wednesday, October 16th from 12 noon to 1 pm.

In the webinar, Dr. Vahdat will help viewers explore:

  • the latest clinical trial findings and their impact on today’s available treatment options
  • novel therapies in the research pipeline and the role they may play in future care
  • the latest understanding of what may cause metastasis and how we might prevent it in the future

Click here for more information about the free webinar. Click here to register for the webinar.